Reynders McVeigh Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,582
| Closed | -$423K | – | 206 |
|
|
2024
Q2 | $423K | Hold |
4,582
| – | – | 0.02% | 146 |
|
|
2024
Q1 | $438K | Sell |
4,582
-870
| -16% | -$83.2K | 0.03% | 144 |
|
|
2023
Q4 | $416K | Buy |
5,452
+625
| +13% | +$47.7K | 0.03% | 143 |
|
|
2023
Q3 | $334K | Sell |
4,827
-374
| -7% | -$25.9K | 0.02% | 158 |
|
|
2023
Q2 | $491K | Sell |
5,201
-165
| -3% | -$15.6K | 0.03% | 138 |
|
|
2023
Q1 | $444K | Buy |
5,366
+275
| +5% | +$22.8K | 0.03% | 143 |
|
|
2022
Q4 | $380K | Sell |
5,091
-77
| -1% | -$5.75K | 0.03% | 160 |
|
|
2022
Q3 | $427K | Buy |
5,168
+1,055
| +26% | +$87.2K | 0.03% | 150 |
|
|
2022
Q2 | $391K | Hold |
4,113
| – | – | 0.03% | 165 |
|
|
2022
Q1 | $484K | Hold |
4,113
| – | – | 0.03% | 158 |
|
|
2021
Q4 | $533K | Sell |
4,113
-1
| -0% | -$130 | 0.03% | 159 |
|
|
2021
Q3 | $466K | Hold |
4,114
| – | – | 0.03% | 159 |
|
|
2021
Q2 | $426K | Sell |
4,114
-87
| -2% | -$9.01K | 0.03% | 168 |
|
|
2021
Q1 | $351K | Buy |
4,201
+3
| +0.1% | +$251 | 0.02% | 183 |
|
|
2020
Q4 | $383K | Buy |
4,198
+4
| +0.1% | +$365 | 0.03% | 170 |
|
|
2020
Q3 | $335K | Sell |
4,194
-84
| -2% | -$6.71K | 0.03% | 173 |
|
|
2020
Q2 | $296K | Buy |
4,278
+183
| +4% | +$12.7K | 0.03% | 177 |
|
|
2020
Q1 | $257K | Buy |
4,095
+24
| +0.6% | +$1.51K | 0.03% | 166 |
|
|
2019
Q4 | $317K | Buy |
+4,071
| New | +$317K | 0.03% | 188 |
|